Pilot Study in a Company in Maine-et-Loire to Evaluate the Feasibility, Acceptability, and Impact on the Participation Rate of Awareness of Colorectal Cancer Screening by Occupational Health Teams

The main objective of this pilot study is to implement an awareness campaign for colorectal cancer screening in the workplace, in partnership with the staff of the occupational health service of one of the largest companies in Maine-Loire , and to evaluate the impact of this action on the participation rate of colorectal cancer screening among employees.

Study Overview

• Status: Unknown
• Conditions: Colorectal Cancer
• Intervention / Treatment: Other: awareness campaign

• Study Type: Interventional
• Enrollment (Anticipated): 1400
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: François-Xavier Caroli-Bosc, MDPhD; Phone Number: +33 2 41 35 60 54; Email: FX.Caroli-Bosc@chu-angers.fr

Study Locations

• France
  • Angers, France
    • Recruiting
    • Santé au Travail CHU Angers
    • Contact: Pierrre RUCAY, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 50 years to 66 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• The study population is made up of the employees of the CHU d'Angers included in the target population of organized colorectal cancer screening in the Maine-et-Loire so employees aged 50 and over.

Exclusion Criteria:

• The criteria for non-inclusion are those of organized screening for colorectal cancer taking into account the active population:
• Age <50 years and> 67 years
• Personal or family history of polyps or colorectal cancer
• Personal history of intestinal disease already undergoing colonoscopy surveillance (chronic inflammatory bowel disease, HNPCC syndrome, familial adenomatous polyposis)
• Known genetic disease with risk of developing colorectal cancer.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Screening
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
variation of the rate of participation in colorectal cancer screening	effective variation (after versus prior to awareness raising) of the overall rate of participation in colorectal cancer screening among employees of the company after 2 years.	2 years

Collaborators and Investigators

• Sponsor: University Hospital, Angers
• Investigators: Principal Investigator: François-Xavier Caroli-Bosc, MDPhD, University Hospital, Angers

Study record dates

Study Major Dates

• Study Start (Actual): June 18, 2018
• Primary Completion (Anticipated): April 1, 2020
• Study Completion (Anticipated): January 1, 2021

Study Registration Dates

• First Submitted: March 2, 2018
• First Submitted That Met QC Criteria: March 2, 2018
• First Posted (Actual): March 8, 2018

Study Record Updates

• Last Update Posted (Actual): July 2, 2018
• Last Update Submitted That Met QC Criteria: June 29, 2018
• Last Verified: June 1, 2018

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Digestive System Diseases; Neoplasms; Neoplasms by Site; Gastrointestinal Neoplasms; Digestive System Neoplasms; Gastrointestinal Diseases; Colonic Diseases; Intestinal Diseases; Intestinal Neoplasms; Rectal Diseases; Colorectal Neoplasms
• Other Study ID Numbers: DETECT

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No